Skip to main content
HIV researchers acknowledge it’s difficult to stay ahead of a virus that can remain deadly after major mutations, but they’re hopeful a variety of new antiretroviral strategies will improve the long-term outlook for HIV patients.

New classes of HIV inhibitors raise promise for future treatments

November 1, 2004

HIV researchers acknowledge its difficult to stay ahead of a virus that can remain deadly after major mutations, but theyre hopeful a variety of new antiretroviral strategies will improve the long-term outlook for HIV patients.